Image

Ophtalmological Characteristics of Patients With Craniosynostosis Followed at the Amiens University Hospital

Ophtalmological Characteristics of Patients With Craniosynostosis Followed at the Amiens University Hospital

Recruiting
All
Phase N/A

Powered by AI

Overview

Craniosynostosis are cranial deformations due to the premature closure of one or more cranial sutures. These deformations affect approximately one in 2.500 births. In the vast majority of cases, craniosynostoses are isolated (non-syndromic) and their origin is not always known. On the other hand, 20% of these deformations are said to be syndromic.

Craniosynostosis has morphological (associated dysmorphism) and functional (growth conflict between the skull and the brain) repercussions. Ophthalmological disorders are frequent: refractive disorders, oculomotor disorders, optic nerve damage, sensory damage.

This study aims to describe the ophthalmological clinical characteristics associated with craniosynostosis in patients followed at the Amiens University Hospital. This is a retrospective study based on the analysis of patient records followed in our center.

Eligibility

Inclusion Criteria:

  • Diagnosis of craniostenosis

Exclusion Criteria:

  • Posterior plagiocephalia

Study details
    Craniosynostosis
    Strabismus
    Intracranial Hypertension
    Amblyopia

NCT06928727

Centre Hospitalier Universitaire, Amiens

14 May 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.